PURPOSE: The aim of this study was to evaluate the correlation between embryonic early-cleavage status and the age of patients receiving either a GnRH agonist long protocol or a GnRH antagonist protocol. METHODS: This retrospective study included 534 patients undergoing a fresh cycle of oocyte retrieval and day-3 embryo transfer. Of the 534 patients treated, 331 received a GnRH agonist long stimulation protocol (GnRH agonist group) for ovarian stimulation and 203 patients received a GnRH antagonist protocol (GnRH antagonist group). RESULTS: By logistic regression analysis, the rate of embryonic early-cleavage was significantly decreased with increasing age of women in the agonist (P < 0.001) but not in antagonist groups (P = 0.61). Based on the results of this study, maternal age is a critical factor for embryonic early-cleavage in agonist protocol but not in antagonist protocol. The results also showed that early-cleavage embryos were of better quality and resulted in a higher pregnancy rate than late-cleavage embryos in the GnRH agonist group. However, embryo quality and pregnancy rate was not significantly different between early and late cleavage embryos in the GnRH antagonist group. CONCLUSIONS: We conclude that embryonic early-cleavage status is negatively correlated with aging in women receiving GnRH agonist long down-regulation but not in GnRH antagonist protocols. We also conclude that early cleavage of the zygote is not a reliable predictor for pregnancy potential using the GnRH antagonist protocol.
PURPOSE: The aim of this study was to evaluate the correlation between embryonic early-cleavage status and the age of patients receiving either a GnRH agonist long protocol or a GnRH antagonist protocol. METHODS: This retrospective study included 534 patients undergoing a fresh cycle of oocyte retrieval and day-3 embryo transfer. Of the 534 patients treated, 331 received a GnRH agonist long stimulation protocol (GnRH agonist group) for ovarian stimulation and 203 patients received a GnRH antagonist protocol (GnRH antagonist group). RESULTS: By logistic regression analysis, the rate of embryonic early-cleavage was significantly decreased with increasing age of women in the agonist (P < 0.001) but not in antagonist groups (P = 0.61). Based on the results of this study, maternal age is a critical factor for embryonic early-cleavage in agonist protocol but not in antagonist protocol. The results also showed that early-cleavage embryos were of better quality and resulted in a higher pregnancy rate than late-cleavage embryos in the GnRH agonist group. However, embryo quality and pregnancy rate was not significantly different between early and late cleavage embryos in the GnRH antagonist group. CONCLUSIONS: We conclude that embryonic early-cleavage status is negatively correlated with aging in women receiving GnRH agonist long down-regulation but not in GnRH antagonist protocols. We also conclude that early cleavage of the zygote is not a reliable predictor for pregnancy potential using the GnRH antagonist protocol.
Authors: N Prapas; Y Prapas; Y Panagiotidis; S Prapa; P Vanderzwalmen; R Schoysman; G Makedos Journal: Hum Reprod Date: 2005-04-28 Impact factor: 6.918
Authors: O Hamdine; N S Macklon; M J C Eijkemans; J S E Laven; B J Cohlen; A Verhoeff; P A van Dop; R E Bernardus; C B Lambalk; G J E Oosterhuis; C A G Holleboom; G C van den Dool-Maasland; H J Verburg; P F M van der Heijden; A Blankhart; B C J M Fauser; F J Broekmans Journal: Hum Reprod Date: 2013-10-15 Impact factor: 6.918
Authors: D Hlinka; B Kaľatová; I Uhrinová; S Dolinská; J Rutarová; J Rezáčová; S Lazarovská; M Dudáš Journal: Physiol Res Date: 2012-08-08 Impact factor: 1.881
Authors: E M Kolibianakis; J Collins; B C Tarlatzis; P Devroey; K Diedrich; G Griesinger Journal: Hum Reprod Update Date: 2006-08-18 Impact factor: 15.610
Authors: M Wilding; B Dale; M Marino; L di Matteo; C Alviggi; M L Pisaturo; L Lombardi; G De Placido Journal: Hum Reprod Date: 2001-05 Impact factor: 6.918